NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

I agree but I do believe they decided to disclose TLD with MHRA approval.

And if the MHRA is so close, why has their oncology committee (OHEAG) not even discussed it as of 1/20/22? That would happen well prior to approval.

More significantly, there is no reason they cannot get a paper published if they want to. Regardless of what the results are, it is still a P3 with a novel agent in a serious indication.

The only explanation of a journal not being willing to publish would be the paper is not providing what a paper wants. And if they cannot do so for a paper, they are going to have serious issues with RAs who want substantially more information.